Ubs Group Ag Idera Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
BUY
$0.23 - $0.43 $10,308 - $19,271
44,818 Added 200.47%
67,174 $23,000
Q3 2022

Nov 10, 2022
BUY
$0.38 - $0.53 $3,503 - $4,886
9,219 Added 70.18%
22,356 $8,000
Q2 2022

Aug 10, 2022
BUY
$0.32 - $0.74 $948 - $2,194
2,965 Added 29.15%
13,137 $6,000
Q1 2022

May 16, 2022
SELL
$0.41 - $0.7 $2,720 - $4,645
-6,636 Reduced 39.48%
10,172 $5,000
Q4 2021

Feb 14, 2022
BUY
$0.53 - $1.03 $5,301 - $10,303
10,003 Added 146.99%
16,808 $9,000
Q3 2021

Nov 15, 2021
BUY
$1.0 - $1.18 $5,417 - $6,392
5,417 Added 390.27%
6,805 $7,000
Q2 2021

Aug 13, 2021
SELL
$1.01 - $1.58 $1,995 - $3,122
-1,976 Reduced 58.74%
1,388 $2,000
Q1 2021

May 12, 2021
SELL
$1.23 - $5.98 $3,190 - $15,512
-2,594 Reduced 43.54%
3,364 $4,000
Q4 2020

Feb 11, 2021
SELL
$2.09 - $5.18 $1,072 - $2,657
-513 Reduced 7.93%
5,958 $22,000
Q3 2020

Nov 12, 2020
SELL
$1.71 - $2.68 $3,505 - $5,494
-2,050 Reduced 24.06%
6,471 $14,000
Q2 2020

Jul 31, 2020
BUY
$1.23 - $2.12 $1,751 - $3,018
1,424 Added 20.06%
8,521 $15,000
Q1 2020

May 01, 2020
BUY
$1.06 - $2.15 $2,676 - $5,428
2,525 Added 55.23%
7,097 $9,000
Q4 2019

Feb 14, 2020
SELL
$1.45 - $2.79 $3,419 - $6,578
-2,358 Reduced 34.03%
4,572 $8,000
Q3 2019

Nov 14, 2019
SELL
$2.12 - $3.31 $502 - $784
-237 Reduced 3.31%
6,930 $20,000
Q2 2019

Aug 14, 2019
BUY
$2.37 - $3.97 $10,428 - $17,468
4,400 Added 159.02%
7,167 $19,000
Q1 2019

May 14, 2019
SELL
$2.33 - $3.79 $28,868 - $46,958
-12,390 Reduced 81.74%
2,767 $7,000
Q4 2018

Feb 14, 2019
BUY
$2.77 - $9.38 $17,847 - $60,435
6,443 Added 73.94%
15,157 $42,000
Q3 2018

Nov 14, 2018
BUY
$5.53 - $11.36 $48,188 - $98,991
8,714 New
8,714 $78,000

Others Institutions Holding IDRA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IDERA PHARMACEUTICALS, INC.

IDRA Quotes by TradingView
  • Ticker IDRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,296,900
  • Market Cap $188M
  • Description
  • Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...
More about IDRA
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email